Skip to content
10-Q

Quarterly Report

SAVIENT PHARMACEUTICALS INC

0001193125-13-442309

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 11, 2013 73.37M sh
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$61.96M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$94.6M
Long Term Debt Q3 2013 · Sep 30, 2013 $235.73M
Long Term Debt Q3 2013 · Dec 31, 2012 $222.91M
Short Term Investments Q3 2013 · Sep 30, 2013 $6.18M
Short Term Investments Q3 2013 · Dec 31, 2012 $45.95M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $28.44M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $50.33M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $68.19M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $114.09M
Stockholders Equity Q3 2013 · Sep 30, 2013 −$206.32M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$138.3M
Current Liabilities Q3 2013 · Sep 30, 2013 $23.96M
Current Liabilities Q3 2013 · Dec 31, 2012 $31.62M
Current Assets Q3 2013 · Sep 30, 2013 $47.38M
Current Assets Q3 2013 · Dec 31, 2012 $109.31M
Total Assets Q3 2013 · Sep 30, 2013 $56.14M
Total Assets Q3 2013 · Dec 31, 2012 $119.21M
Sga Expense Q3 2013 · Sep 30, 2013 $14.32M
Sga Expense Q3 2013 · Sep 30, 2013 $47.28M
Sga Expense Q3 2013 · Sep 30, 2012 $20.43M
Sga Expense Q3 2013 · Sep 30, 2012 $72.01M
Rd Expense Q3 2013 · Sep 30, 2013 $4.15M
Rd Expense Q3 2013 · Sep 30, 2013 $16.31M
Rd Expense Q3 2013 · Sep 30, 2012 $6.8M
Rd Expense Q3 2013 · Sep 30, 2012 $20.75M
Net Income Q3 2013 · Sep 30, 2013 −$20.43M
Net Income Q3 2013 · Sep 30, 2013 −$70.31M
Net Income Q3 2013 · Sep 30, 2012 −$39.7M
Net Income Q3 2013 · Sep 30, 2012 −$90.28M
Operating Income Q3 2013 · Sep 30, 2013 −$13.32M
Operating Income Q3 2013 · Sep 30, 2013 −$52.68M
Operating Income Q3 2013 · Sep 30, 2012 −$26.53M
Operating Income Q3 2013 · Sep 30, 2012 −$92.35M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $1.42M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $7.01M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $4.22M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $12.67M
Revenue Q3 2013 · Sep 30, 2013 $6.57M
Revenue Q3 2013 · Sep 30, 2013 $17.92M
Revenue Q3 2013 · Sep 30, 2012 $4.92M
Revenue Q3 2013 · Sep 30, 2012 $13.08M